- Home
- TIL vs MRCC Comparison
TIL vs MRCC Comparison
Compare TIL & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- MRCC
- Stock Information
- Founded
- TIL 2018
- MRCC 2011
- Country
- TIL United States
- MRCC United States
- Employees
- TIL N/A
- MRCC N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- MRCC Investment Managers
- Sector
- TIL Health Care
- MRCC Finance
- Exchange
- TIL Nasdaq
- MRCC Nasdaq
- Market Cap
- TIL 170.7M
- MRCC 174.8M
- IPO Year
- TIL 2021
- MRCC 2012
- Fundamental
- Price
- TIL $21.17
- MRCC $8.25
- Analyst Decision
- TIL Buy
- MRCC Strong Buy
- Analyst Count
- TIL 4
- MRCC 1
- Target Price
- TIL $100.33
- MRCC $9.00
- AVG Volume (30 Days)
- TIL 107.5K
- MRCC 71.5K
- Earning Date
- TIL 11-13-2024
- MRCC 11-12-2024
- Dividend Yield
- TIL N/A
- MRCC 12.15%
- EPS Growth
- TIL N/A
- MRCC 298.01
- EPS
- TIL N/A
- MRCC 0.60
- Revenue
- TIL N/A
- MRCC $62,007,000.00
- Revenue This Year
- TIL N/A
- MRCC N/A
- Revenue Next Year
- TIL $2.65
- MRCC N/A
- P/E Ratio
- TIL N/A
- MRCC $13.71
- Revenue Growth
- TIL N/A
- MRCC N/A
- 52 Week Low
- TIL $6.72
- MRCC $6.77
- 52 Week High
- TIL $92.00
- MRCC $8.74
- Technical
- Relative Strength Index (RSI)
- TIL 36.47
- MRCC 42.19
- Support Level
- TIL $20.57
- MRCC $8.20
- Resistance Level
- TIL $22.69
- MRCC $8.66
- Average True Range (ATR)
- TIL 2.72
- MRCC 0.19
- MACD
- TIL -0.23
- MRCC -0.06
- Stochastic Oscillator
- TIL 2.98
- MRCC 1.85
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.